Axel Hoos - Researcher Profile | RDL Research Database

Publications

2 shown

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

F. Stephen Hodi , Steven O’Day , David F. McDermott +26 more

Ipilimumab, with or without a gp100 peptide vaccine, as compared with gp100 alone, improved overall survival in patients with previously treated metastatic melanoma. Adverse eve...

2010 New England Journal of Medicine 14794 citations

Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma

Caroline Robert , L. Thomas , Igor Bondarenko +21 more

Ipilimumab (at a dose of 10 mg per kilogram) in combination with dacarbazine, as compared with dacarbazine plus placebo, improved overall survival in patients with previously un...

2011 New England Journal of Medicine 4405 citations

Frequent Co-Authors

Robert Weber

Jeffrey A. Sosman

Vanderbilt University Medical Center

John B.A.G. Haanen

The Netherlands Cancer Institute

Researcher Info

h-index: 2
Publications: 2
Citations: 19,199
Institution: Bristol-Myers Squibb (United States)

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0001-5269-9376

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.